Ecromeximab
id:
ecromeximab-320-12081998
title:
Ecromeximab
text:
Ecromeximab is a chimeric monoclonal antibody being developed for the treatment of malignant melanoma. The drug was developed by Kyowa Hakko Kogyo Co., Ltd. As of December 2015 development had been discontinued.
brand slug:
wiki
category slug:
encyclopedia
description:
Monoclonal antibody
original url:
https://en.wikipedia.org/wiki/Ecromeximab
date created:
date modified:
2023-12-31T06:04:39Z
main entity:
{"identifier":"Q3718768","url":"https://www.wikidata.org/entity/Q3718768"}
image:
fields total:
13
integrity:
14